ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Relmada Therapeutics Inc

Relmada Therapeutics Inc (RLMD)

0.3958
0.0336
( 9.28% )
Updated: 12:36:52

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -38.7M-28.15M-26.03M-22.69M-26.83M-22.99M-18.82M-23.01M
Pre Tax Income -37.95M-26.32M-25.3M-22M-25.17M-21.83M-17.77M-21.73M
Net Income -37.95M-26.32M-25.3M-22M-25.17M-21.83M-17.77M-21.73M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -32.35M-28.15M-26.03M-22.69M-26.83M-22.99M-18.82M-23.01M
EBITDA -38.7M-28.15M-26.03M-22.69M-26.83M-22.99M-18.82M-23.01M
Year End December 30 2023 20172018201920192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -7.22M-6.92M-12.73M-8.27M-60.84M-125.7M-161.25M-103.7M
Pre Tax Income -6.29M-8.96M-17.32M-8.2M-59.46M-125.75M-157.04M-98.79M
Net Income -6.29M-8.96M-17.32M-8.2M-59.46M-125.75M-157.04M-98.79M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.502-0.714-0.444-0.567-3.64-4.533-5.218-3.282
EBIT -7M-6.92M-16.5M-8.27M-60.84M-125.7M-154.9M-103.7M
EBITDA -7.22M-6.92M-12.73M-8.27M-60.84M-125.7M-161.25M-103.7M